TNF-α is a potent immunomodulatory and proinflammatory cytokine that mediates inflammatory diseases and is produced by activated macrophages. [7, 8] TNF-α (-308) AA and AG genotypes have the potential to produce higher levels of TNF-α, whereas the GG genotype produces lower levels of TNF-α. [9] IL-6 is a proinflammatory cytokine and plays a key role in acute and chronic inflammation, affecting the endocrine and other systems, such as the central nervous and cardiovascular systems. [10] Both the GG and GC genotypes of IL 6 (-174) are associated with increased levels of IL-6, while the CC genotype leads to decreased expression of this cytokine. [11] IFN-γ has immunomodulatory, antimicrobial, antiproliferative, and antifibrotic activities and also modulates the production or activities of several cytokines. [12] The IFN-γ (+874) AA genotype is associated with lower production, TA with intermediate production, and TT with higher production of this cytokine. [13] The aim of this study was to explore any association between the polymorphisms and expression levels of the three cytokine genes and clinical parameters in children who underwent cochlear implantation because of profound congenital sensorineural hearing loss.
Materials and Methods
In total, 64 unrelated patients with suspicion of congenital sensorineural hearing loss and 70 healthy controls were included in this study. The patients had no history of perinatal infections, and tests for viral markers for hepatitis and HIV were negative. Patients with syndromic hearing loss, malformed inner ears, or multiple handicaps were excluded. The preoperative evaluation included a medical history, a physical examination, and a battery of audiological tests (otoacoustic emissions, evoked response audiometry, behavioral audiometry, and ASSR). Imaging studies of the temporal bone were also performed. All the children then underwent cochlear implantation with Med-El (MED-EL, Innsbruck, Austria) or Nucleus (Cochlear Corp., Lane Cove, New South Wales, Australia) cochlear implants. The study was approved by the University of Gaziantep Ethics Committee of Clinical Research. All parents of the children gave their informed consent for inclusion in this study. DNA was isolated from blood samples and the IL-6/-174, IFN-γ/+874, and TNF-α/-308 cytokine genes were analyzed. Cytokine genotyping/expression testing was performed using the PCR-SSP method, [14] and all data were analyzed using the de Finetti program [15] and SPSS software (ver. 14.0 for Windows; SPSS Inc., Chicago, IL, USA).
Results
Allele frequencies and genotype distributions of the IL-6, IFN-γ, and TNF-α genes in patients and controls are shown in Table 1 . There were no significant differences between the patient group and healthy controls among the distribution or number of genotypes and alleles for TNF-α or IL-6. The TT genotype, associated with higher IFN-
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Baysal E et al. γ expression, and the T allele frequency were found to be significantly more frequent in the patient group than in the controls (p=0.016 and 0.023, respectively). The observed genotype counts did not deviate significantly from those expected according to Hardy-Weinberg equilibrium (p>0.05). No relationship was found between the cytokine genotypes and clinical parameters of the patients.
Discussion
IFN-γ or type II interferon is a cytokine vital for innate and adaptive immunity against viral infections and intracellular bacterial infections and for tumor control. Aberrant IFN-γ expression is associated with numerous autoinflammatory and autoimmune diseases. [6] The significance of IFN-γ in the immune system stems partly from its ability to directly inhibit viral replication. Most importantly, its immunostimulatory and immunomodulatory effects are mediated predominantly by natural killer (NK) and natural killer T (NKT) cells as part of the innate immune response (and by CD4 and CD8 cytotoxic T lymphocytes (CTLs), which are effector T cells, once antigen-specific immunity develops). A functional SNP at position +874 of the human IFN-γ gene, correlating with differential cytokine production, was reported by Pravica et al. [6, 14, 16] The polymorphism lies within a binding site for the transcription factor NF-κB, and electrophoretic mobility shift assays showed specific binding of NF-κB to the allelic sequence containing the +874T allele. As this transcription factor induces IFN-γ expression, the +874T and +874A alleles likely correlate with high and low IFN-γ expression, respectively. The transcription factor NF-κB also preferentially binds to the +874T allele, which was overrepresented in the controls, suggesting that genetically determined variability in IFN-γ expression may be important for the development of tuberculosis. [16] [17] [18] [19] Neutralizing IFN-γ completely prevented both vascular dysfunction and changes in NOS expression, and neutralizing TNF reduced IFN-γ production and partially prevented dysfunction. Inhibiting iNOS partially preserved responses to NO at two weeks and reduced graft intimal expansion after four weeks in vivo. In fact, Koh et al. concluded that IFN-γ was a central mediator of vascular dysfunction through the dysregulation of NO production. Adhesion development was also found to depend on the IFN-γ and STAT1 system, and NKT cell-deficient mice developed poor adhesion. However, these mice developed severe adhesion after reconstitution with NKT cells from wild-type mice, suggesting that the production of IFN-γ by NKT cells is indispensable for adhesion formation. [20] In a study by Alper et al., it is suggested that IFN-γ gene polymorphism predisposes a patient to otitis during an upper respiratory infection. [5] Matkovic et al. studied the cytokine levels of bilateral ears in patients with otitis media with effusion and they found that the immune response of the same patient can be different in each ear. [21] Aminpour et al. studied the role of TNF-α in patients with sensorineural hearing loss after bacterial meningitis and they concluded that TNF-α plays an important role in cochlear injury after bacterial meningitis. [22] According to these findings, if there is an intrauterine infection and inflammation even the immune response of the same patient might be different and this immune response can result with susceptibility for cochlear injury. According to the results of this study, silent infections in the perinatal period may contribute to congenital profound sensorineural hearing loss. To the best of our knowledge, the relationship between cytokine genotypes/ expression and clinical parameters in patients with congenital hearing loss has not been investigated. Our results suggest that high expression of the IFN-γ gene may be associated with susceptibility to the disease.
Conclusion
Consequently, IFN-γ may be a useful marker for disease etiopathogenesis in patients with congenital sensorineural hearing loss especially in patients who had perinatal silent infections. There are major limitations in this study; one is the limited number of the patients with hearing loss and the second one is the markers of major viral markers were not ruled out, this was because of the limited budget. Our results allow us to make only preliminary conclusions due to the small sample size. Further studies designed with eliminating major viral infectious diseases and with larger number of patients are needed.
